Catalent Stock Jumps on $16.5 Billion Sale to Controlling Shareholder of Ozempic Maker Novo Nordisk
Catalent Stock Jumps on $16.5 Billion Sale to Controlling Shareholder of Ozempic Maker Novo Nordisk
Upworthy
0 shares
1 views
You might like
Related news coverage
Stock Pops 10% on Sale to Novo Nordisk
Upworthy
CTLT stock is up with heavy trading on the news Catalent (NYSE:CTLT) stock is climbing higher on Monday after the company agreed to..